Skip to content

Yi-Chyan Chen

7 papers in the library · 13 citations · publishing 2016-2026

Papers

Sort Most recent Most cited

Biological variations in ketamine sensitivity: insights from hyperlocomotion to psychotomimetic features in genetically diverse mouse strains.

Psychiatry Research April 1, 2026 Wen-Huei Siao, Tzong-Shi Wang, Liang-Chun Wang et al.

Ketamine, a non-competitive NMDA receptor antagonist, induces dissociative and psychotomimetic states and is widely used as an animal model for schizophrenia. However, strain-dependent variability in ketamine sensitivity is poorly understood, especially during adolescence, a developmental period marked by heightened vulnerability to NMDA receptor hypofunction. This study would compare...

DOI: 10.1016/j.psychres.2026.116995 (opens in new tab) Full text (opens in new tab) Animal model Genetic diversity Ketamine sensitivity Nmda receptor hypofunction +1

Gastrodin Mitigates Ketamine-Induced Inhibition of F-Actin Remodeling and Cell Migration by Regulating the Rho Signaling Pathway.

Biomedicines March 6, 2025 Ping-Cheng Shih, I-Shiang Tzeng, Yi-Chyan Chen et al. 1 citation

Background/Objects: Rho signaling plays a role in calcium-regulated cytoskeletal reorganization and cell movement, processes linked to neuronal function and cancer metastasis. Gastrodia elata, a traditional herbal medicine, can regulate glutamate-induced calcium influx in PC12 cells and influence cell function by modulating neuronal cytoskeleton remodeling via the monoaminergic system and Rho...

Age, Dose, and Locomotion: Decoding Vulnerability to Ketamine in C57BL/6J and BALB/c Mice.

Biomedicines June 25, 2023 Wen-Chien Chen, Tzong-Shi Wang, Fang-Yu Chang et al. 12 citations

Ketamine has been abused as a psychedelic agent and causes diverse neurobehavioral changes. Adolescence is a critical developmental stage but vulnerable to substances and environmental stimuli. Growing evidence shows that ketamine affects glutamatergic neurotransmission, which is important for memory storage, addiction, and psychosis. To explore diverse biological responses, this study was...

Modified Transcendental Meditation Intervention for Nurses via an Application User Group Accessed on Smartphones: Effects of Anxiety and Depression on Sleep Quality

Journal of Sleep Disorders Treatment & Care 2018 Ru‐Wen Liao, Chin Min Huang, Pei Shan Hung et al.

Background: Sleep quality plays an important role in the overall health of nurses, which may influence the quality of patient care provided by nurses. The LINE messaging app is a commonly used tool for sending messages easily and quickly. Therefore, in this study, to improve sleep quality among nurses, we designed and implemented an intervention with modified transcendent meditation (MTM),...

N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.

Progress in Neuro-Psychopharmacology and Biological Psychiatry November 3, 2016 Jen-Cheng Lin, Ming‐huan Chan, Mei-Yi Lee et al.

Ketamine, a dissociative anesthetic, produces rapid and sustained antidepressant effects at subanesthtic doses. However, it still inevitably induces psychotomimetic side effects. N,N-dimethylglycine (DMG) is a derivative of the amino acid glycine and is used as a dietary supplement. Recently, DMG has been found acting at glycine binding site of the N-methyl-d-aspartate receptor (NMDAR). As...

DOI: 10.1016/j.pnpbp.2016.06.002 (opens in new tab) Full text (opens in new tab) Anesthesia Forced swimming Glycine Nmda receptor +1

Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.

Psychopharmacology September 2016 Jen-Cheng Lin, Mei-Yi Lee, Ming‐huan Chan et al.

Ketamine is emerging as a new hope against depression, but ketamine-associated psychotomimetic effects limit its clinical use. An adjunct therapy along with ketamine to alleviate its adverse effects and even potentiate the antidepressant effects might be an alternative strategy. Betaine, a methyl derivative of glycine and a dietary supplement, has been shown to have antidepressant-like effects...

PM285. Neuropharmacological effect of ketamine-induced hyperlocomotion modulated by age in the C57BL/6J mice

The International Journal of Neuropsychopharmacology May 27, 2016 Yi-Chyan Chen

Background: Ketamine, an antagonist on N-methyl-D-aspartate (NMDA) receptor, can produce neurobehavioral changes ranging from mood alterations and psychotic episodes in human to hyperactivity and stereotyped motion in mice. In the study, we tested the pharmacological properties of ketamine on anxiety, locomotion and motor activity. Materials and Methods: Subjects were C57BL/6J mice with age of...